세계의 의약품 ADMET 시험 시장 보고서(2025년)

Pharmaceutical ADMET testing encompasses a series of methodologies and assays employed in the pharmaceutical sector to evaluate the Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) characteristics of drug candidates. This essential process is instrumental in gauging the safety and effectiveness of prospective drugs prior to obtaining regulatory approval for clinical application.

The primary categories of pharma ADMET testing include in vivo ADMET testing, in vitro ADMET testing, and in silico ADMET testing. In vivo ADMET testing involves the analysis of a drug's absorption, distribution, metabolism, excretion, and toxicity attributes within a living organism. Widely utilized throughout drug discovery and development phases, pharma ADMET testing plays a crucial role in pinpointing potential drug candidates endowed with favorable pharmacokinetic properties. Utilizing advanced technologies such as cell culture, high throughput, molecular imaging, and OMICS, pharma ADMET testing is pivotal in assessing systemic toxicity, renal toxicity, hepatotoxicity, neurotoxicity, and other relevant parameters. This comprehensive approach aids in the strategic identification of drug candidates that align with desired efficacy and safety profiles, thereby contributing to informed decision-making in the pharmaceutical business landscape.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The pharma ADMET testing market research report is one of a series of new reports from The Business Research Company that provides pharma ADMET testing market statistics, including the pharma ADMET testing industry's global market size, regional shares, competitors with a pharma ADMET testing market share, detailed pharma ADMET testing market segments, market trends, and opportunities, and any further data you may need to thrive in the pharma ADMET testing industry. This pharma ADMET testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharma admet testing market size has grown rapidly in recent years. It will grow from $9.67 billion in 2024 to $10.7 billion in 2025 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to growth in biopharmaceuticals and biosimilars, rise in drug development activities, growing awareness of drug safety, globalization of clinical trials, shift towards in silico modeling.

The pharma admet testing market size is expected to see rapid growth in the next few years. It will grow to $17.03 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to environmental toxicology and safety assessment, awareness of pharmacogenomics, focus on precision medicine, growth of biologics and biosimilars, integration of artificial intelligence (AI), expanded regulatory requirements, rise in orphan drug development. Major trends in the forecast period include increasing collaboration in research, rapid technological innovations, advancements in analytical technologies, continuous monitoring of drug safety, and environmental impact considerations.

The forecast of 12.3% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. drug developers by driving up the cost of high-throughput ADMET screening systems and 3D liver microtissues sourced from Belgium and Japan, exacerbating R&D expenses and delaying new drug approvals. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing number of product approvals is fueling the growth of the pharma ADMET testing market. Product approvals refer to the process through which regulatory authorities, such as the Food and Drug Administration (FDA) in the United States or the European Medicines Agency (EMA) in Europe, authorize a product for marketing and sale to the public. ADMET testing is essential for assessing the safety and efficacy of new products and is a requirement in regulatory approvals. For example, in January 2024, the National Library of Medicine, a US-based biomedical library and a national resource for health professionals, reported that the U.S. Food and Drug Administration (FDA) approved 55 new drugs in 2023, an increase from 37 drugs approved in 2022. Therefore, the rising number of product approvals is driving the pharma ADMET testing market.

The surge in clinical trials is expected to drive the pharma ADMET testing market's growth in the future. Clinical trials, essential research studies involving human participants, evaluate the safety, efficacy, and potential side effects of medical interventions, including new drugs, medical devices, diagnostic procedures, or treatment regimens. The escalating number of clinical trials significantly amplifies the demand for comprehensive assessments of drug safety and efficacy within the pharma ADMET testing market. For example, a report from Xtalks reveals that, as of May 2023, there are 452,604 registered clinical studies on ClinicalTrials.gov, indicating a notable increase from the over 365,000 trials recorded in early 2021. This uptick underscores the industry's growing need for tailored evaluations across diverse drug candidates and patient populations, thereby propelling the pharma ADMET testing market's expansion.

A prominent trend gaining traction in the pharma ADMET testing market is the focus on product innovations, with major companies introducing cutting-edge solutions to enhance their market position. Notably, Charles River Laboratories International Inc. and Valo Health Inc. launched Logica in April 2022-an AI-based drug development solution. Leveraging Valo's Opal Computational Platform, Logica provides users with ADMET testing services and other drug delivery solutions. The solution incorporates industry-leading predictive models, chemical design and synthesis capabilities, DNA-encoded libraries, and in silico high-throughput screening. Charles River's expertise in various discovery optimization aspects, including high-throughput screening, medicinal chemistry, ADME, biology, pharmacology, safety testing, and IND submission, further enhances Logica's capabilities.

Major players in the pharma ADMET testing market are strategically engaging in partnerships to advance efforts in discovering allosteric drugs. An illustrative example is the collaboration between Excelra and HotSpot Therapeutics Inc. In May 2022, Excelra, specializing in accelerating drug discovery through advanced data science, partnered with HotSpot Therapeutics Inc., a biotechnology company focused on small molecule allosteric therapies. This strategic alliance involves integrating Excelra's product, GOSTAR, and its annotated datasets into HotSpot's machine learning (ML) and artificial intelligence (AI) models. GOSTAR, with insights into over 8 million small molecules, provides comprehensive information on chemical structures and various biological properties, facilitating the exploration and development of small molecule therapeutic candidates targeting challenging allosteric sites.

In September 2022, BioIVT, a prominent drug development solutions provider based in the United States, successfully completed the acquisition of XenoTech for an undisclosed sum. This strategic move is designed to enhance BioIVT's product portfolio by integrating XenoTech's capabilities and to facilitate the expansion of its product offerings into new geographic regions, thereby reaching a broader customer base. XenoTech, a respected US-based contract research organization, specializes in offering ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) testing services. This acquisition underscores BioIVT's commitment to strengthening its position in the drug development sector by incorporating complementary expertise and extending its reach to cater to evolving market demands.

Major companies operating in the pharma ADMET testing market include Thermo Fisher Scientific Inc., The Merck Group, Laboratory Corporation of America Holdings, IQVIA Inc., PPD ICON plc, Agilent Technologies Inc., Wuxi AppTec Co. Ltd., Catalent Inc., Covance Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, Beckman Coulter Inc., Perkinelmer Inc., Albany Molecular Research Inc., Evotec A.G., CMIC Holdings Co. Ltd., Promega Corporation, Aptuit LLC, Symeres B.V., Biovia Corp., BioIVT LLC, Cyprotex Limited, InSphero AG, Admescope Ltd., Accelrys Inc.

Asia-Pacific was the largest region in the pharma ADMET testing market in 2024. The regions covered in the pharma admet testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharma admet testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharma ADMET testing market consists of revenues earned by entities by providing services such as in vitro screening, in vitro metabolism, and metabolite testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharma ADMET testing market also includes the sales of membranes, buffer systems, and analytes that are used in the assays. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharma ADMET Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharma admet testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharma admet testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pharma admet testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Testing Type: In Vivo ADMET Testing; In Vitro ADMET Testing; In Silico ADMET Testing
• 2) By Technology: Cell Culture; High Throughput; Molecular Imaging; OMICS Technology
• 3) By Application: Systemic Toxicity; Renal Toxicity; Hepatotoxicity; Neurotoxicity; Other Applications
• Subsegments:
• 1) By In Vivo ADMET Testing: Animal Studies; Pharmacokinetics Studies; Toxicology Studies; Biodistribution Studies
• 2) By In Vitro ADMET Testing: Metabolism Studies; Drug-Drug Interaction Studies; Absorption Studies; Cytotoxicity and Safety Testing
• 3) By In Silico ADMET Testing: Predictive Modeling and Simulation; Quantitative Structure-Activity Relationship (QSAR) Analysis; Machine Learning Algorithms for ADMET Predictions; Software Tools for ADMET Profiling
• Companies Mentioned: Thermo Fisher Scientific Inc.; The Merck Group; Laboratory Corporation of America Holdings; IQVIA Inc.; PPD ICON plc; Agilent Technologies Inc.; Wuxi AppTec Co. Ltd.; Catalent Inc.; Covance Inc.; Charles River Laboratories International Inc.; Eurofins Scientific SE; Beckman Coulter Inc.; Perkinelmer Inc.; Albany Molecular Research Inc.; Evotec A.G.; CMIC Holdings Co. Ltd.; Promega Corporation; Aptuit LLC; Symeres B.V.; Biovia Corp.; BioIVT LLC; Cyprotex Limited; InSphero AG; Admescope Ltd.; Accelrys Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharma ADMET Testing Market Characteristics

3. Pharma ADMET Testing Market Trends And Strategies

4. Pharma ADMET Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Pharma ADMET Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pharma ADMET Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pharma ADMET Testing Market Growth Rate Analysis
• 5.4. Global Pharma ADMET Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pharma ADMET Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pharma ADMET Testing Total Addressable Market (TAM)

6. Pharma ADMET Testing Market Segmentation

• 6.1. Global Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• In Vivo ADMET Testing
• In Vitro ADMET Testing
• In Silico ADMET Testing
• 6.2. Global Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cell Culture
• High Throughpu
• Molecular Imaging
• OMICS Technology
• 6.3. Global Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Systemic Toxicity
• Renal Toxicity
• Hepatotoxicity
• Neurotoxicity
• Other Applications
• 6.4. Global Pharma ADMET Testing Market, Sub-Segmentation Of In Vivo ADMET Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Animal Studies
• Pharmacokinetics Studies
• Toxicology Studies
• Biodistribution Studies
• 6.5. Global Pharma ADMET Testing Market, Sub-Segmentation Of In Vitro ADMET Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Metabolism Studies
• Drug-Drug Interaction Studies
• Absorption Studies
• Cytotoxicity and Safety Testing
• 6.6. Global Pharma ADMET Testing Market, Sub-Segmentation Of In Silico ADMET Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Predictive Modeling and Simulation
• Quantitative Structure-Activity Relationship (QSAR) Analysis
• Machine Learning Algorithms for ADMET Predictions
• Software Tools for ADMET Profiling

7. Pharma ADMET Testing Market Regional And Country Analysis

• 7.1. Global Pharma ADMET Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pharma ADMET Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharma ADMET Testing Market

• 8.1. Asia-Pacific Pharma ADMET Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharma ADMET Testing Market

• 9.1. China Pharma ADMET Testing Market Overview
• 9.2. China Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharma ADMET Testing Market

• 10.1. India Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharma ADMET Testing Market

• 11.1. Japan Pharma ADMET Testing Market Overview
• 11.2. Japan Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharma ADMET Testing Market

• 12.1. Australia Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharma ADMET Testing Market

• 13.1. Indonesia Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharma ADMET Testing Market

• 14.1. South Korea Pharma ADMET Testing Market Overview
• 14.2. South Korea Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharma ADMET Testing Market

• 15.1. Western Europe Pharma ADMET Testing Market Overview
• 15.2. Western Europe Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharma ADMET Testing Market

• 16.1. UK Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharma ADMET Testing Market

• 17.1. Germany Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharma ADMET Testing Market

• 18.1. France Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharma ADMET Testing Market

• 19.1. Italy Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharma ADMET Testing Market

• 20.1. Spain Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharma ADMET Testing Market

• 21.1. Eastern Europe Pharma ADMET Testing Market Overview
• 21.2. Eastern Europe Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharma ADMET Testing Market

• 22.1. Russia Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharma ADMET Testing Market

• 23.1. North America Pharma ADMET Testing Market Overview
• 23.2. North America Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharma ADMET Testing Market

• 24.1. USA Pharma ADMET Testing Market Overview
• 24.2. USA Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharma ADMET Testing Market

• 25.1. Canada Pharma ADMET Testing Market Overview
• 25.2. Canada Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharma ADMET Testing Market

• 26.1. South America Pharma ADMET Testing Market Overview
• 26.2. South America Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharma ADMET Testing Market

• 27.1. Brazil Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharma ADMET Testing Market

• 28.1. Middle East Pharma ADMET Testing Market Overview
• 28.2. Middle East Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharma ADMET Testing Market

• 29.1. Africa Pharma ADMET Testing Market Overview
• 29.2. Africa Pharma ADMET Testing Market, Segmentation By Testing Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pharma ADMET Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pharma ADMET Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharma ADMET Testing Market Competitive Landscape And Company Profiles

• 30.1. Pharma ADMET Testing Market Competitive Landscape
• 30.2. Pharma ADMET Testing Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. The Merck Group Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. IQVIA Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. PPD ICON plc Overview, Products and Services, Strategy and Financial Analysis

31. Pharma ADMET Testing Market Other Major And Innovative Companies

• 31.1. Agilent Technologies Inc.
• 31.2. Wuxi AppTec Co. Ltd.
• 31.3. Catalent Inc.
• 31.4. Covance Inc.
• 31.5. Charles River Laboratories International Inc.
• 31.6. Eurofins Scientific SE
• 31.7. Beckman Coulter Inc.
• 31.8. Perkinelmer Inc.
• 31.9. Albany Molecular Research Inc.
• 31.10. Evotec A.G.
• 31.11. CMIC Holdings Co. Ltd.
• 31.12. Promega Corporation
• 31.13. Aptuit LLC
• 31.14. Symeres B.V.
• 31.15. Biovia Corp.

32. Global Pharma ADMET Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharma ADMET Testing Market

34. Recent Developments In The Pharma ADMET Testing Market

35. Pharma ADMET Testing Market High Potential Countries, Segments and Strategies

• 35.1 Pharma ADMET Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pharma ADMET Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pharma ADMET Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer